Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dimethyl fumarate, a two‐edged drug: Current status and future directions
Nathaniel Edward Bennett Saidu, Niloufar Kavian, Karen Leroy, et al.
Medicinal Research Reviews (2019) Vol. 39, Iss. 5, pp. 1923-1952
Closed Access | Times Cited: 120

Showing 1-25 of 120 citing articles:

An Activity-Guided Map of Electrophile-Cysteine Interactions in Primary Human T Cells
Ekaterina V. Vinogradova, Xiaoyu Zhang, David Remillard, et al.
Cell (2020) Vol. 182, Iss. 4, pp. 1009-1026.e29
Open Access | Times Cited: 272
NRF2 as a Therapeutic Target in Neurodegenerative Diseases
Mikah S. Brandes, Nora E. Gray
ASN NEURO (2020) Vol. 12, pp. 175909141989978-175909141989978
Open Access | Times Cited: 200
Antioxidant Therapy in Cancer: Rationale and Progress
Maochao Luo, Li Zhou, Zhao Huang, et al.
Antioxidants (2022) Vol. 11, Iss. 6, pp. 1128-1128
Open Access | Times Cited: 101
Ferroptosis‐modulating small molecules for targeting drug‐resistant cancer: Challenges and opportunities in manipulating redox signaling
Solveigh C. Koeberle, Anna P. Kipp, Hermann Stuppner, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 3, pp. 614-682
Open Access | Times Cited: 46
An Overview of the History, Pathophysiology, and Pharmacological Interventions of Multiple Sclerosis
Ibrahim M Dighriri, Ahood A Aldalbahi, Fatimah Albeladi, et al.
Cureus (2023)
Open Access | Times Cited: 39
Disrupting pro-survival and inflammatory pathways with dimethyl fumarate sensitizes chronic lymphocytic leukemia to cell death
Maria Elena Mantione, Miriam Meloni, Ilenia Sana, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 13
Emerging role of NRF2 in ROS-mediated tumor chemoresistance
Danfeng Xue, Xiongming Zhou, Jiaxuan Qiu
Biomedicine & Pharmacotherapy (2020) Vol. 131, pp. 110676-110676
Open Access | Times Cited: 128
The role of natural products in revealing NRF2 function
Donna D. Zhang, Eli Chapman
Natural Product Reports (2020) Vol. 37, Iss. 6, pp. 797-826
Open Access | Times Cited: 95
NRF2 Regulation Processes as a Source of Potential Drug Targets against Neurodegenerative Diseases
Ángel Cores, Marta Piquero, Mercedes Villacampa, et al.
Biomolecules (2020) Vol. 10, Iss. 6, pp. 904-904
Open Access | Times Cited: 69
Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies
Jean Bousquet, Jean‐Paul Cristol, Heather J. Zar, et al.
Clinical and Translational Allergy (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 69
Pathway network of pyroptosis and its potential inhibitors in acute kidney injury
Ning Li, Yuru Wang, Xinyue Wang, et al.
Pharmacological Research (2021) Vol. 175, pp. 106033-106033
Closed Access | Times Cited: 69
Targeting NRF2 to treat cancer
Jared Sivinski, Donna D. Zhang, Eli Chapman
Seminars in Cancer Biology (2021) Vol. 76, pp. 61-73
Open Access | Times Cited: 61
Inflammation, Fibrosis and Cancer: Mechanisms, Therapeutic Options and Challenges
Bocheng Wu, Quaovi H. Sodji, Adegboyega K. Oyelere
Cancers (2022) Vol. 14, Iss. 3, pp. 552-552
Open Access | Times Cited: 58
Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers
Lin Li, Qing Wu, Feifei Lu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 30
Novel potential pharmacological applications of dimethyl fumarate—an overview and update
Giorgia Bresciani, Federico Manai, Sergio Davinelli, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 21
Dimethyl fumarate inhibits necroptosis and alleviates systemic inflammatory response syndrome by blocking the RIPK1-RIPK3-MLKL axis
Fuli Shi, Li-sha Yuan, Tak-sui Wong, et al.
Pharmacological Research (2023) Vol. 189, pp. 106697-106697
Open Access | Times Cited: 19
Gasdermin‐E‐Dependent Non‐Canonical Pyroptosis Promotes Drug‐Induced Liver Failure by Promoting CPS1 deISGylation and Degradation
Shen‐Xi Ouyang, Jiahui Zhu, Qi Cao, et al.
Advanced Science (2024) Vol. 11, Iss. 16
Open Access | Times Cited: 8
Modulation of Keap1/Nrf2/ARE Signaling Pathway by Curcuma- and Garlic-Derived Hybrids
Melania Maria Serafini, Michele Catanzaro, Francesca Fagiani, et al.
Frontiers in Pharmacology (2020) Vol. 10
Open Access | Times Cited: 60
Beetroot, A Remarkable Vegetable: Its Nitrate and Phytochemical Contents Can be Adjusted in Novel Formulations to Benefit Health and Support Cardiovascular Disease Therapies
Diego dos Santos Baião, Davi Vieira Teixeira da Silva, Vânia Margaret Flosi Paschoalin
Antioxidants (2020) Vol. 9, Iss. 10, pp. 960-960
Open Access | Times Cited: 60
Activation of the Nrf2/HO-1 signaling pathway by dimethyl fumarate ameliorates complete Freund's adjuvant-induced arthritis in rats
Roshan Lal, Jatinder Dhaliwal, Navneet Dhaliwal, et al.
European Journal of Pharmacology (2021) Vol. 899, pp. 174044-174044
Closed Access | Times Cited: 48
Nanotechnology-Based Drug Delivery to Improve the Therapeutic Benefits of NRF2 Modulators in Cancer Therapy
Zerrin Sezgin Bayındır, Sonia Losada‐Barreiro, Carlos Bravo‐Díaz, et al.
Antioxidants (2021) Vol. 10, Iss. 5, pp. 685-685
Open Access | Times Cited: 42
Current Understanding of Long-Term Cognitive Impairment After Sepsis
Ying Li, Mu‐Huo Ji, Jianjun Yang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 34
Dimethyl fumarate: A review of preclinical efficacy in models of neurodegenerative diseases
I. Majkutewicz
European Journal of Pharmacology (2022) Vol. 926, pp. 175025-175025
Closed Access | Times Cited: 33
Constructing fluorine-doped Zr-MOF films on titanium for antibacteria, anti-inflammation, and osteogenesis
Bangcheng Yan, Ji Tan, Haifeng Zhang, et al.
Biomaterials Advances (2022) Vol. 134, pp. 112699-112699
Closed Access | Times Cited: 26
Novel Insights into PARK7 (DJ-1), a Potential Anti-Cancer Therapeutic Target, and Implications for Cancer Progression
Wook Jin
Journal of Clinical Medicine (2020) Vol. 9, Iss. 5, pp. 1256-1256
Open Access | Times Cited: 43
Page 1 - Next Page

Scroll to top